← Back to Clinical Trials
Recruiting NCT06950125

Evaluation of the JUICE HA® as an Anti-sarcopenia

Trial Parameters

Condition Sarcopenia in Elderly
Sponsor China Medical University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 65 Years
Max Age N/A
Start Date 2025-06-23
Completion 2025-12-31
Interventions
PlaceboJUICE HA® supplement

Brief Summary

This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.

Eligibility Criteria

Inclusion Criteria: * Participants that have been diagnosed with sarcopenia by a physician and meet the AWGS 2019 criteria for sarcopenia. Exclusion Criteria: * Participants with a history of severe lower extremity musculoskeletal injuries within the past six months or those who have a fear of blood sampling will be excluded.

Related Trials